8. Market Access
8.1 Overview of Healthcare System, Finland
8.2 Reimbursement of Medicinal Products, Finland
8.3 Overview of Insurance Providers, Public Insurance, Finland
8.4 Overview of Insurance Providers, Private Insurance, Finland
8.5 Healthcare Spending and Prescription Drug Price Trend, Finland
8.6 Pricing Policies, Finland
8.7 Regulatory Landscape, Finland
8.7.1 Marketing Authorization for Pharmaceutical Products, EU
8.7.2 Market Authorization for Pharmaceutical Products (Centralized Procedure), Finland
8.7.3 Market Authorization for Pharmaceutical Products (Decentralized Procedure), Finland
8.7.4 Market Authorization for Pharmaceutical Products (Mutual Recognition Procedure), Finland
8.7.5 Marketing Authorization for Pharmaceutical Products (National Procedure), Finland
8.7.6 Marketing Authorization for Medical Devices, Finland
8.7.7 Intellectual Property Rights, European Patent, Finland
8.7.8 Intellectual Property Rights, Unitary Patent, Finland
8.7.9 Intellectual Property Rights, Patent, Finland
8.7.10 Intellectual Property Rights, Trademark, Finland
8.7.11 Clinical Trial Regulation, Finland
8.7.12 Pharmaceutical Clinical Trials Landscape, Finland
8.7.13 Medical Devices Clinical Trials Landscape, Finland
8.7.14 Pharmaceutical Export and Import, Finland
8.7.15 Pharmaceutical Advertising Regulations, Finland
8.7.16 Pharmacy Regulations, Finland
8.7.17 Labeling and Packaging Regulations, Finland
9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Finland
9.2 Healthcare Facilities, Finland
9.3 Healthcare Parameters, Finland
9.4 Life Expectancy and Immunization Rate, Finland
9.5 Environmental Health, Finland
9.6 Healthcare Personnel, Finland
9.7 Disease Burden, Finland
9.8 Healthcare Expenditure, Finland
10 Trade Associations, Finland
11 Trade Fairs, Finland
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About
13.4 Contact Us
13.5 Disclaimer
List of Tables
Table 1: Approved Biosimilars, Finland 2015-2021
Table 2: Major Therapeutic Areas by Sales Value ($M), Finland, 2018
Table 3: COVID-19 Indicators (Number of Cases), Global and Finland, 2020-2021
Table 4: COVID-19-Related Travel Restrictions, Finland, 2020-2021
Table 5: Finland's Estimated Share of the EU's Vaccine Procurement, COVID-19, Finland, 2020-2021
Table 6: COVID-19 IVD Products, Finland, 2020-2021
Table 7: List of COVID-19 Clinical Trials Sponsors by Count, Finland, 2020-2021
Table 8: Medical Device Market, Finland, Major Segments ($M), 2020
Table 9: Orthopedic Devices Market, Finland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Hospital Supplies Market, Finland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: General Surgery Market, Finland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Cardiovascular Devices Market, Finland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 13: Diabetes Care Devices Market, Finland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 14: Major Laws related to Digital Health, Finland , 2004-2019
Table 15: Reimbursement Categories, Finland, 2021
Table 16: Exceptional Copayment Rate for Specific Medicines, Finland, 2021
Table 17: Medicine Retail Price at the Pharmacy, Finland, 2019
Table 18: Market Authorization Fees, Finland, 2021
Table 19: Patent Fees, Finland, 2021
Table 20: Trademark Fees, Finland, 2021
Table 21: Package Label Information, Finland, 2021
List of Figures
Figure 1: Pharmaceutical Market, Finland, Revenue ($B and €B), 2013-2020
Figure 2: Medical Device Market, Finland, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Finland, 2021
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Finland, 2020
Figure 7: Pharmaceutical Market, Finland, Revenue ($B and €B), 2013-2020
Figure 8: Pharmaceutical Market, Finland, Revenue Forecast ($B and €B), 2021-2025
Figure 9: Pharmaceutical Exports ($B), Finland, 2013-2020
Figure 10: Top Export Partners, Finland, 2020
Figure 11: Pharmaceutical Imports ($B), Finland, 2013-2020
Figure 12: Top Import Partners, Finland, 2020
Figure 13: Pharmaceutical Supply Channel, Finland, 2021
Figure 14: Medicines Verification System, Finland, 2021
Figure 15: Product Flow in Medicines Verification System, Finland, 2021
Figure 16 Generic Share by Value (%) , Finland, 2012-2018
Figure 17: Generic Share by Volume (%) , Finland, 2012-2018
Figure 18: OTC Medicines Market, Major Distribution Channels ($M), Finland, 2020
Figure 19: OTC Medicines Market, Revenue ($M), Finland, 2013-2020
Figure 20: OTC Medicines Market, Major Categories ($M), Finland, 2020
Figure 21: Top Five Therapeutic Areas by Annual Revenue (%), Finland, 2018
Figure 22: COVID-19 Cases, Finland, 2020-2021
Figure 23: COVID-19 Deaths, Finland, 2020-2021
Figure 24: COVID-19 Fiscal Stimulus Timeline, Finland, 2020-2021
Figure 25: Three Phases of the Epidemic, Finland, 2021
Figure 26: COVID-19 Co-ordination and Management, Finland, 2021
Figure 27: COVID-19 Co-ordination Group, Finland, 2021
Figure 28: Government Plan for Lifting the Restrictions Imposed Due to COVID-19, Finland, 2020-2021
Figure 29: COVID-19 Vaccination Progress, Finland, 2021
Figure 30: Vaccination Distribution for COVID-19, Finland, 2020-2021
Figure 31: COVID-19 Clinical Trials Count by Trial Status, Finland, 2020-2021
Figure 32: COVID-19 Clinical Trials Count by Phase, Finland, 2020-2021
Figure 33: Medical Devices Market, Finland, Revenue ($B), 2015-2020
Figure 34: Medical Devices Market, Finland, Revenue Forecast ($B), 2021-2025
Figure 35: Medical Device Market, Finland, Major Segments (%), 2020
Figure 36: Orthopedic Devices Market, Finland, Revenue ($M), 2017-2025
Figure 37: Orthopedic Devices Market, Finland, Market Share of Major Players (%), 2020
Figure 38: Hospital Supplies Market, Finland, Revenue ($M), 2017-2025
Figure 39: Hospital Supplies Market, Finland, Market Share of Major Players (%), 2020
Figure 40: General Surgery Market, Finland, Revenue ($M), 2017-2025
Figure 41: General Surgery Market, Finland, Market Share of Major Players (%), 2020
Figure 42: Cardiovascular Devices Market, Finland, Revenue ($M), 2017-2025
Figure 43: Cardiovascular Devices Market, Finland, Market Share of Major Players (%), 2020
Figure 44: Diabetes Care Devices Market, Finland, Revenue ($M), 2017-2025
Figure 45: Diabetes Care Devices Market, Finland, Market Share of Major Players (%), 2020
Figure 46:Diagnostics Market, Finland, Revenue ($M), 2015-2020
Figure 47: Diagnostics Market, Finland, Revenue Forecast ($M), 2021-2025
Figure 48: Medical Devices Market, Revenue ($B) of Major Companies, Finland, 2020
Figure 49: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2019-2021
Figure 50: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Finland, 2019-2021
Figure 51: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Finland, 2019-2021
Figure 52: Top Therapy Areas by Deal Value, Pharmaceutical Market, Finland, 2019-2021
Figure 53: Top Therapy Areas by Deal Count, Pharmaceutical Market, Finland, 2019-2021
Figure 54: M&A Deals by Quarter, Pharmaceutical Market, Finland, 2019-2021 (by value and by number)
Figure 55: VC Deals by Quarter, Pharmaceutical Market, Finland, 2019-2021 (by value and by number)
Figure 56: Deal Value and Deal Count, Medical Devices Market, Finland, 2019-2021
Figure 57: Deal Value and Deal Count Subtypes, Medical Devices Market, Finland, 2019-2021
Figure 58: Deal Value and Deal Count, Quarterly, Medical Devices Market, Finland, 2019-2021
Figure 59: Top Equipment Sectors by Deal Value, Medical Devices Market, Finland, 2019-2021
Figure 60: Top Equipment Sectors by Deal Count, Medical Devices Market, Finland, 2019-2021
Figure 61: M&A Deals by Equipment Sector, Medical Devices Market, Finland, 2019-2021 (by Value and by Number)
Figure 62: VC Deals by Quarter, Medical Devices Market, Finland, 2019-2021 (by Value and by Number)
Figure 63: Health Incubator Helsinki Process, Finland, 2021
Figure 64: Health Incubator Helsinki First Batch, Finland, 2020
Figure 65: Deal Value ($M), HealthTech, Finland, 2020-2021
Figure 66: Deal Count (Number of Deals), HealthTech, Finland, 2020-2021
Figure 67: GDPR Compliance Checklist, EU, 2021
Figure 68: Organization of the Health System, Finland, 2019
Figure 69: Medical Reimbursement System, Finland, 2021
Figure 70: Financial Flow, Finland, 2021
Figure 71: NHI Expenditure by Benefit (€M), Finland, 2019
Figure 72: Financing of Healthcare by NHI (€M), Finland, 2019
Figure 73: Private Health Insurance Coverage (% Total Population), Finland, 2021
Figure 74: OOP Expenditure (% of Total Expenditure on Health), Finland, 2012-2020
